Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Neutron

Rocket Lab Has Corrected Nearly 50%. Is It Still Too Expensive?

Rocket Lab shares have fallen over 50% since May after Piper Sandler's Neutral rating cited valuation concerns, even as backlog, contracts, and Neutron progress keep the bull case alive.

MarketBeat

Watch Archimedes burn! Rocket Lab fires up engine for its powerful next-gen Neutron launcher (video)

Rocket Lab recently performed a full-duration static fire test with the engine that will power the second stage of its powerful new Neutron launch vehicle.

Space

Rocket Lab’s Stock Drop Comes With a Bullish Twist

Rocket Lab stock is down 45% from its peak, but a record-fast Space Force launch, Morgan Stanley's $293 bull case, and the Iridium deal highlight bullish fundamentals ahead of Aug. 6 earnings.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Rocket Lab Just Changed Its Growth Story With One Bold $8B Deal

This blockbuster acquisition gives Rocket Lab something it lacked before.

Barchart

Rocket Lab vs. Redwire: 1 Stock Has the Stronger Growth Story for the Next Decade

The SpaceX IPO may have opened a new chapter for space investing. Between Rocket Lab and Redwire, one has the more intriguing long-term growth story.

Barchart

Dear Rocket Lab Stock Fans, Mark Your Calendars for June 22

RKLB will be added to the Nasdaq-100 next week.

Barchart

Rocket Lab Is Down 24% From Its 52-Week High—Pullback or Problem?

Rocket Lab's 18% pullback from its 52-week high appears to reflect normal consolidation rather than any deterioration in business fundamentals.

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

Despite Positive Developments, Rocket Lab Stock Is a High-Risk Name

Rocket Lab is having trouble with a key rocket.

Barchart

Rocket Lab Stock Is Getting a Major Lift. Investors Are Betting on Its Neutron Launch Later This Year.

Rocket Lab stock is blasting higher as investors bet on the growing demand for Neutron launches, which could position it as a serious competitor in the medium-lift rocket market.

Barchart

Forget the SpaceX IPO: Why Rocket Lab Is the Smarter Space Stock Buy

SpaceX’s IPO could become one of the market’s biggest events, but history suggests mega IPOs often disappoint after launch. Rocket Lab is taking a different path with growing revenue, expanding capabilities, and a proven launch business.

Barchart

The Space Race Just Hit a Bottleneck—Who Benefits?

Blue Origin's grounding of New Glenn after an April 19 mishap tightens an already-constrained launch market, potentially benefiting RKLB, FLY, and LUNR.

MarketBeat

Does Rocket Lab's $2 Billion Backlog Offset Dilution Concerns?

Rocket Lab’s $190 million hypersonic contract has propelled its backlog beyond $2 billion, capping a busy week that also included an equity raise announcement. Investors need to balance explosive contract growth against fresh dilution pressures.

Barchart

Rocket Lab Finds Its Footing as Post-Earnings Support Takes Shape

Rocket Lab is stabilizing after an almost 30% pullback from record-highs, with shares holding key support and potentially forming a higher low.

MarketBeat

RKLB Delivers Record Results, But Neutron Delay Weighs on Shares

Rocket Lab (NASDAQ: RKLB) posted record revenue in 2025, expanded margins, and a $1.85 billion backlog, with strong near-term visibility.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Rocket Lab Earnings Loom as Neutron Timeline Takes Center Stage

Rocket Lab (NASDAQ: RKLB) shares have pulled back nearly 30% from their highs ahead of a pivotal fourth-quarter earnings report.

MarketBeat

Rocket Lab’s Neutron Hiccup Sparked a Sell-Off—Overreaction or Omen?

Understand why Rocket Lab pulled back from January highs, what the Neutron testing incident means, and the key levels and catalysts investors are watching.

Space

Rocket Lab's 'Hungry Hippo' Neutron fairing arrives at spaceport in Virginia

The "hungry hippo" fairing for Rocket Lab's new Neutron launch vehicle has arrived for integration at the company's Virginia Spaceport facilities.

MarketBeat

Analysts Remain Steadfast on Rocket Lab After Neutron Test Failure

Shares of Rocket Lab have fallen nearly 20% from recent record highs, following a Neutron test failure and uncertainty about its launch schedule.

Get all your
news in one place.

100's of premium titles.
One news app.

Space

Rocket Lab's new Neutron rocket suffers fuel tank rupture during test

Rocket Lab's first Neutron rocket buckled under pressure when its main stage tank ruptured during an overnight test in Wallops, Virginia.

MarketBeat

Rocket Lab Gets a Big Upgrade: Will Upside Follow?

Morgan Stanley just turned bullish on Rocket Lab, upgrading the stock to Overweight from Equalweight and raising its price target to a Street-high $105.

MarketBeat

5 Stocks Retail Investors Are Betting on for 2026

Retail stock picks have shown real edge in recent years, with previous retail favorites like NVIDIA, Palantir, and Robinhood outperforming the market.

Barchart

As SpaceX Readies for Massive IPO, This Is the Space Stock You Should Be Buying

Amid anticipation for SpaceX’s historic IPO, Rocket Lab shines as an accessible and high-potential space stock with impressive 2025 gains, innovative advancements, and analyst backing for continued growth.

MarketBeat

Why 2026 Could Be Another Breakout Year for Rocket Lab

Rocket Lab has delivered exceptional performance, with shares up nearly 175% year to date, yet remains early in a catalyst-rich growth phase heading into 2026.

Space

Rocket Lab's 'Hungry Hippo' passes final test ahead of 1st reusable Neutron rocket launch

Rocket Lab has signed a contract to launch its new Neutron rocket on a test flight that will advance the U.S. Air Force's point-to-point cargo transportation concept.

MarketBeat

Rocket Lab’s Big Rebound? Analysts Suggest the Dip's a Gift

Analyst sentiment remains strong, with consensus price targets rising steadily to a record $58.17 despite RKLB’s sharp recent pullback.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.